JTC Team, LLC (NASDAQ:VLON) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
JTC Team, LLC

BRIEF

published on 07/24/2024 at 19:29, 3 months 27 days ago

Sonnet BioTherapeutics (NASDAQ:SONN) Participates in JTC Team's Virtual Investor Segment

Clinical Trial Sonnet BioTherapeutics Immunotherapeutic Drugs Virtual Investor JTC Team
PRESS RELEASE

published on 07/24/2024 at 19:24, 3 months 27 days ago

Sonnet BioTherapeutics (NASDAQ:SONN) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
JTC Team releases 'What This Means' segment featuring Sonnet BioTherapeutics discussing encouraging data from ongoing clinical trial. Virtual presentation available now

Investor Relations Clinical Trial Sonnet BioTherapeutics Immunotherapeutic Drugs JTC Team
BRIEF

published on 06/17/2024 at 14:05, 5 months 3 days ago

Final Line-Up Announced for JTC Team’s Virtual Investor Pitch Conference

Virtual Conference JTC Team Investor Pitch Company Line-Up
PRESS RELEASE

published on 06/17/2024 at 14:00, 5 months 3 days ago

Final Participating Company Line-Up Announced for the Virtual Investor Pitch Conference Hosted by JTC Team Being Held June 17 - 18, 2024
JTC announces final line-up for Virtual Investor Pitch Conference on June 17-18, 2024, featuring live webcast presentations by various companies at www.virtualinvestorco.com

Investor Relations JTC Team Virtual Investor Pitch Conference Webcast Presentations Event Schedule
BRIEF

published on 06/12/2024 at 16:05, 5 months 8 days ago

Outlook Therapeutics (NASDAQ: OTLK) to Participate in Virtual Investor Closing Bell Series

Webcast Outlook Therapeutics Virtual Investor Closing Bell Series Russell Trenary ONS-5010
PRESS RELEASE

published on 06/12/2024 at 16:00, 5 months 8 days ago

Outlook Therapeutics(R) (NASDAQ: OTLK) to Participate Virtual Investor Closing Bell Series
Outlook Therapeutics, Inc. to participate in virtual investor event hosted by JTC Team, providing corporate overview and business outlook on June 13, 2024 at 4:00 PM ET

Investor Event JTC Team Outlook Therapeutics Virtual Webcast Retina Diseases
BRIEF

published on 06/10/2024 at 14:05, 5 months 10 days ago

JTC Team Announces Participating Company Line-Up for the Virtual Investor Pitch Conference on June 17-18, 2024

Investor Relations Live Webcast Virtual Conference Financial Events JTC Team 10:00 AM ET: Adolore BioTherapeutics – Webcast 11:00 AM ET: CNS Pharmaceuticals, Inc. – Webcast 12:00 PM ET: Palisade Bio, Inc. – Webcast 1:00 PM ET: AIM ImmunoTech Inc. – Webcast 4:00 PM ET: EnVVeno Medical Corporation – Webcast 10:00 AM ET: Royalty Management Holding Corporation – Webcast 11:00 AM ET: GRI Bio, Inc. – Webcast 12:00 PM ET: Outlook Therapeutics, Inc. – Webcast 1:00 PM ET: American Resources Corporation – Webcast 3:00 PM ET: Moleculin Biotech, Inc. – Webcast
PRESS RELEASE

published on 06/10/2024 at 14:00, 5 months 10 days ago

JTC Team Announces Participating Company Line-Up for the Virtual Investor Pitch Conference on June 17-18, 2024
JTC Team to host Virtual Investor Pitch Conference on June 17-18, 2024, featuring live webcast presentations with Q&A sessions. Participating companies include Adolore BioTherapeutics, CNS Pharmaceuticals, Palisade Bio, AIM ImmunoTech, enVVeno Medical, Royalty Management Holding, GRI Bio, Outlook Therapeutics, American Resources Corp, and Moleculin Biotech

Investor Relations JTC Team Virtual Investor Pitch Conference Webcast Presentations Participating Companies
BRIEF

published on 06/06/2024 at 16:35, 5 months 14 days ago

Outlook Therapeutics Receives European Authorization for LYTENAVA™

JTC Team Outlook Therapeutics LYTENAVA™ European Authorization Wet AMD
PRESS RELEASE

published on 06/06/2024 at 16:30, 5 months 14 days ago

Outlook Therapeutics(R) (NASDAQ:OTLK) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Outlook Therapeutics receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for wet AMD treatment. Watch the 'What This Means' video featuring CEO Russ Trenary

European Commission JTC Team Outlook Therapeutics LYTENAVA Wet AMD Treatment

Accesswire

Published on 11/21/2024 at 10:03, 45 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 48 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 48 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 13 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 23 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 18 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 43 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 45 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 48 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 48 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 50 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 28 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 3 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 3 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE